glp 1 agonist pharmacology Trends in the Development of GLP-1 Receptor Agonists GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
Instead, Dr
Importantly, none of the studies reported any worsening of headaches with GLP-1 RAs
At the 1mg dose, roughly 14% of participants reported nausea
Novo Nordisk was provided with the opportunity to perform a medical accuracy review
Competing interests All authors declare that there are no conflict of interests or special relationships with industry in this meta-analysis
Side effects included nausea (44%), vomiting (24%), diarrhea (30%), constipation (24%), abdominal pain (20%), headache (14%), fatigue (11%), dizziness (8%), abdominal distension (7%), and belching (7%)
